|
Biotech News IP law update Regular intellectual property news from Australia and overseas. |
India's patent law reforms draws in Merck
July 22 – India has recently made it illegal for unauthorised parties to manufacture patented drugs. Following a 20 year absence, Merck will now re-enter the Indian market via a wholly owned subsidiary, MSD Pharmaceuticals Private. Merck stated that the tightening of India's patent laws helped in its return and is considering the establishment of manufacturing and research units in the near future. India is the world's fourth largest producer of medicines by volume, but ranks 13th by market value.
[Source: Reuters]
